Tumour burden and efficacy of immune-checkpoint inhibitors
FG Dall'Olio, A Marabelle, C Caramella… - Nature reviews Clinical …, 2022 - nature.com
Accumulating evidence suggests that a high tumour burden has a negative effect on
anticancer immunity. The concept of tumour burden, simply defined as the total amount of …
anticancer immunity. The concept of tumour burden, simply defined as the total amount of …
Risks from deferring treatment for genitourinary cancers: a collaborative review to aid triage and management during the COVID-19 pandemic
Context The coronavirus disease 2019 (COVID-19) pandemic is leading to delays in the
treatment of many urologic cancers. Objective To provide a contemporary picture of the risks …
treatment of many urologic cancers. Objective To provide a contemporary picture of the risks …
Kidney cancer, version 3.2022, NCCN clinical practice guidelines in oncology
The NCCN Guidelines for Kidney Cancer focus on the screening, diagnosis, staging,
treatment, and management of renal cell carcinoma (RCC). Patients with relapsed or stage …
treatment, and management of renal cell carcinoma (RCC). Patients with relapsed or stage …
Management of metastatic clear cell renal cell carcinoma: ASCO guideline
WK Rathmell, RB Rumble… - Journal of Clinical …, 2022 - ingentaconnect.com
PURPOSE To provide recommendations for the management of patients with metastatic
clear cell renal cell carcinoma (ccRCC). METHODS An Expert Panel conducted a systematic …
clear cell renal cell carcinoma (ccRCC). METHODS An Expert Panel conducted a systematic …
[HTML][HTML] Radiotherapy to the primary tumour for newly diagnosed, metastatic prostate cancer (STAMPEDE): a randomised controlled phase 3 trial
CC Parker, ND James, CD Brawley, NW Clarke… - The Lancet, 2018 - thelancet.com
Background Based on previous findings, we hypothesised that radiotherapy to the prostate
would improve overall survival in men with metastatic prostate cancer, and that the benefit …
would improve overall survival in men with metastatic prostate cancer, and that the benefit …
Comparison of immediate vs deferred cytoreductive nephrectomy in patients with synchronous metastatic renal cell carcinoma receiving sunitinib: the SURTIME …
Importance In clinical practice, patients with primary metastatic renal cell carcinoma (mRCC)
have been offered cytoreductive nephrectomy (CN) followed by targeted therapy, but the …
have been offered cytoreductive nephrectomy (CN) followed by targeted therapy, but the …
Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
B Escudier, C Porta, M Schmidinger… - Annals of …, 2019 - annalsofoncology.org
Kidney cancer accounts for 5% and 3% of all adult malignancies in men and women,
respectively, thus representing the 7th most common cancer in men, and the 10th most …
respectively, thus representing the 7th most common cancer in men, and the 10th most …
NCCN guidelines insights: kidney cancer, version 2.2020: featured updates to the NCCN guidelines
The NCCN Guidelines for Kidney Cancer provide multidisciplinary recommendations for the
clinical management of patients with clear cell and non–clear cell renal cell carcinoma, and …
clinical management of patients with clear cell and non–clear cell renal cell carcinoma, and …
Clinical review on the management of metastatic renal cell carcinoma
J Tran, MC Ornstein - JCO Oncology Practice, 2022 - ascopubs.org
Renal cell carcinomas vary considerably in their tumor biology and disease course, which is
reflected in the range of treatment paradigms in localized and metastatic renal cell …
reflected in the range of treatment paradigms in localized and metastatic renal cell …
Towards individualized therapy for metastatic renal cell carcinoma
Over the past decade, the treatment landscape for patients with metastatic renal cell
carcinoma (RCC) has evolved dramatically. The therapeutic options available have …
carcinoma (RCC) has evolved dramatically. The therapeutic options available have …